Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Mol Cancer Ther. 2017 Jun 27;16(10):2120–2129. doi: 10.1158/1535-7163.MCT-17-0176

Figure 7.

Figure 7

a. CPPI inhibition of relapsed LNCaP xenograft tumor growth. Response of LNCaP tumors relapsed after castration to CPPI treatment or vehicle control. b. Effect of CPPI on PC-3 xenograft tumor growth. Response of PC-3 tumors relapsed after castration. Number of animals in each group is indicated in parentheses. c. Representative images (10–40X) of relative Cas-3+ immunostaining in transverse sections of relapsed LNCaP xenograft tumors treated with CPPI or vehicle control. d. Ki-67 immunostaining in transverse sections of LNCaP xenograft tumors treated with CPPI or vehicle control. e. Quantification of Cas-3 positive cells in LNCaP tumors. f. Quantification of Ki-67 positive cells in LNCaP. Data are representative of 5 different readings from each tumor. Values are presented as mean ± SEM (*, p < 0.05, ***, p < 0.0001).